Also, it has been found that PD-L2 expression is associated with a poor prognosis in patients’ cancer tissues, such as hepatocellular carcinoma [58], and esophageal cancer [59]. The gene discussed is PDCD1LG2; the disease is hepatocellular carcinoma.